These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7742522)

  • 1. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
    Degos L; Dombret H; Chomienne C; Daniel MT; Micléa JM; Chastang C; Castaigne S; Fenaux P
    Blood; 1995 May; 85(10):2643-53. PubMed ID: 7742522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia.
    Cull GM; Eikelboom JW; Cannell PK
    Hematol Oncol; 1997 Feb; 15(1):13-7. PubMed ID: 9378467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.
    Tallman MS; Rowe JM
    Blood Rev; 1994 Jun; 8(2):70-8. PubMed ID: 7950477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid differentiation therapy in promyelocytic leukemia.
    Chomienne C; Fenaux P; Degos L
    FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report.
    Ciccone M; Rigolin GM; Viglione GM; Borrelli M; Serino ML; Cuneo A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):721-3. PubMed ID: 18832917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
    Skotnicki AB; Stoch A; Sacha T; Nowak WS
    Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
    Degos L
    Cancer Treat Res; 1993; 64():1-13. PubMed ID: 8095789
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia.
    Colucciello M
    Arch Ophthalmol; 2003 Jul; 121(7):1064-5. PubMed ID: 12860824
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of acute promyelocytic leukemia.
    Fenaux P
    Eur J Haematol; 1993 Feb; 50(2):65-73. PubMed ID: 8382622
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
    Lakhwani S; Raya JM; González-Brito G; Álvarez-Argüelles H; Brito ML; Hernández-Nieto L
    Pathology; 2011 Aug; 43(5):515-7. PubMed ID: 21753723
    [No Abstract]   [Full Text] [Related]  

  • 18. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
    Limentani SA; Pretell JO; Potter D; DuBois JS; Daoust PR; Spieler PS; Miller KB
    Am J Hematol; 1994 Sep; 47(1):50-5. PubMed ID: 8042616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful continuous treatment with all-trans retinoic acid for acute promyelocytic leukemia; secondary malignancy after the treatment of osteosarcoma.
    Mahmud N; Tsukada T; Taniguchi M; Takahashi T; Kihira H; Sekine T; Miwa H; Kobayashi T; Kita K; Deguchi K
    Intern Med; 1994 Oct; 33(10):654-7. PubMed ID: 7827386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.